SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Lu Wang, Guan-ya Guo, Jing-bo Wang, Xin-min Zhou, Qiong Yang, Zhe-yi Han, Qiang Li, Jing-wen Zhang, Yun Cai, Xiao-li Ren, Xia Zhou, Rui-rui Chen, Yong-quan Shi, Ying Han, Dai-ming Fan, A decline of LAMP- 2 predicts ursodeoxycholic acid response in primary biliary cirrhosis, Scientific Reports, 2015, 5, 9772

    CrossRef

  2. 2
    Hani S Mousa, Ana Lleo, Pietro Invernizzi, Christopher L Bowlus, Merril Eric Gershwin, Advances in pharmacotherapy for primary biliary cirrhosis, Expert Opinion on Pharmacotherapy, 2015, 16, 5, 633

    CrossRef

  3. 3
    Takeji Umemura, Satoru Joshita, Tomohiro Sekiguchi, Yoko Usami, Soichiro Shibata, Takefumi Kimura, Michiharu Komatsu, Akihiro Matsumoto, Masao Ota, Eiji Tanaka, Serum Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein Level Predicts Liver Fibrosis and Prognosis in Primary Biliary Cirrhosis, The American Journal of Gastroenterology, 2015, 110, 6, 857

    CrossRef

  4. 4
    Li Wang, Qin Han, Hua Chen, Ke Wang, Guang-liang Shan, Fang Kong, Yun-jiao Yang, Yong-zhe Li, Xuan Zhang, Fen Dong, Qian Wang, Dong Xu, Zhao-jun Hu, Shi-hua Wang, Armand Keating, Ya-lan Bi, Feng-chun Zhang, Robert Chun-hua Zhao, Allogeneic Bone Marrow Mesenchymal Stem Cell Transplantation in Patients with UDCA-Resistant Primary Biliary Cirrhosis, Stem Cells and Development, 2014, 23, 20, 2482

    CrossRef

  5. 5
    Tomohiro Tanaka, Noriyo Yamashiki, Yasuhiko Sugawara, Sumihito Tamura, Minoru Nakamura, Junichi Kaneko, Taku Aoki, Yoshihiro Sakamoto, Kiyoshi Hasegawa, Norihiro Kokudo, Chronologic changes of explanted liver volume and the use of ursodeoxycholic acid in patients with end-stage primary biliary cirrhosis, Hepatology Research, 2014, 44, 9
  6. 6
    Anthony W H Chan, Ronald C K Chan, Grace L H Wong, Vincent W S Wong, Paul C L Choi, Henry L Y Chan, Ka-Fai To, Evaluation of histological staging systems for primary biliary cirrhosis: correlation with clinical and biochemical factors and significance of pathological parameters in prognostication, Histopathology, 2014, 65, 2
  7. 7
    Kidist K Yimam, Christopher L Bowlus, Obeticholic acid for the treatment of primary biliary cirrhosis, Expert Opinion on Orphan Drugs, 2014, 2, 12, 1351

    CrossRef

  8. 8
    Palak J. Trivedi, Tony Bruns, Angela Cheung, Ka-Kit Li, Clemens Kittler, Teru Kumagi, Husnain Shah, Christopher Corbett, Nadya Al-Harthy, Unsal Acarsu, Catalina Coltescu, Dhiraj Tripathi, Andreas Stallmach, James Neuberger, Harry L.A. Janssen, Gideon M. Hirschfield, Optimising risk stratification in primary biliary cirrhosis: AST/platelet ratio index predicts outcome independent of ursodeoxycholic acid response, Journal of Hepatology, 2014, 60, 6, 1249

    CrossRef

  9. 9
    Avegail Flores, Marlyn J. Mayo, Primary biliary cirrhosis in 2014, Current Opinion in Gastroenterology, 2014, 30, 3, 245

    CrossRef

  10. You have free access to this content10
    Albert Parés, Treatment of primary biliary cirrhosis: Is there more to offer than ursodeoxycholic acid?, Clinical Liver Disease, 2014, 3, 2
  11. 11
    Carlo Selmi, Ian R. Mackay, M. Eric Gershwin, The Autoimmune Diseases, 2014,

    CrossRef